AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
Quanterix Corporation Common Stock
XNAS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG0027NWC78
2.86▲ 0.02 (0.70%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
2.84
Day's Range
2.71 – 2.88
52-Week Range
2.15 – 8.78
Volume
332.6K
Avg Volume
792.1K
Share Statistics
Shares Outstanding
Employees
450
Exchange
XNAS
Listed
2017-12-07
Share count as of August 3, 2026

Quanterix Corporation Common Stock (QTRX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Quanterix Corporation Common Stock (QTRX)
What is Quanterix Corporation Common Stock's Market Cap?
Quanterix Corporation Common Stock's Market Cap is $135.3M, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's Price / Sales?
Quanterix Corporation Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's Revenue (TTM)?
Quanterix Corporation Common Stock's Revenue (TTM) is $153.4M, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's Net Income (TTM)?
Quanterix Corporation Common Stock's Net Income (TTM) is -$123.1M, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's EBITDA?
Quanterix Corporation Common Stock's EBITDA is -$132.9M, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's Diluted EPS (TTM)?
Quanterix Corporation Common Stock's Diluted EPS (TTM) is -2.60, based on as-reported figures from SEC (XBRL) filings.
What is Quanterix Corporation Common Stock's EBITDA Margin?
Quanterix Corporation Common Stock's EBITDA Margin is -86.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · QTRXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Total revenues
YoY growth+34.4%+20.1%+24.7%+12.3%
Costs of goods sold and services:
Total costs of goods sold and services
Gross profit
% of revenue38.5%42.7%45.7%42.8%
Operating expenses:
Research and development
Selling, general and administrative
Impairment and restructuring costs—
Total operating expenses
% of revenue188.7%156.3%102.1%135.5%
Loss from operations
% of revenue-150.2%-113.6%-56.4%-92.8%
Other income (expense), net:
Interest income
Change in fair value of contingent liabilities
Other income (expense), net
Loss before income taxes
Income tax benefit
Net loss
% of revenue-148.7%-48.2%-52.7%-83.3%
Net loss per common share, basic (in dollars per share)
Net loss per common share, diluted (in dollars per share)